Regeneron Pharmaceuticals (REGN) has been in a persistent downtrend for over 280 days. The stock is currently in the 10th Phase of its 18-Phase Adhishthana Cycle, our proprietary cyclical framework. Let's break down why this fall isn't just technical noise and what the Adhishthana Principles reveal about what lies ahead.A Look Back at Regeneron's Adhishthana Cycle so farRegeneron's current cycle began on January 29, 2018, and for much of it, the stock moved in line with Adhishthana’s expectations. The early ...